Tactile Systems Technology, Inc. (TCMD)
Nasdaq: TCMD · Surgical & Medical Instruments & Apparatus · Minneapolis, MN · filing with the SEC since 2002
Grade6.6
◀ Past 6.8● Present 7.0▶ Future 5.7
Who owns Tactile Systems Technology, Inc.
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 7.7% of Common Stock, as its SCHEDULE 13G/A filed Apr 24, 2025 says.
Directors and officers
12
report now, of 30 people on the record since 2016. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 24, 2025 · Common Stock
Cadian Capital Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 4.9% in Feb 17, 2026
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Jan 21, 2026 · Common Stock · reported falling below 5%, from 5% in Jul 15, 2025
Morgan Stanley
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock · reported falling below 5%, from 5.8% in Feb 12, 2026
Paradigm Capital Management Inc/ny
SCHEDULE 13G/A · filed Feb 12, 2026 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 7.06% in Oct 31, 2025
What TCMD reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
AffloVest APA
A company bought · acquisition · Sep 2021 · owns, named in the 10-K filed Feb 17, 2026
Insider tradesForm 4
14sales
0purchases
3sales on a scheduled plan
5people selling
$2.3Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 9, 2025 to Nov 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 39 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Dodd Sheri Louise | Chief Executive Officer | 4 | $1.1M | 0 | 0 | $0 |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | 4 | $500,000 | 0 | 0 | $0 |
| Burns Kristie | Sr. VP Mktg & Clinical Affairs | 4 | $500,000 | 1 | 0 | $0 |
| Burke William W | director | 1 | $100,000 | 1 | 0 | $0 |
| King Laura G. | director | 1 | $100,000 | 1 | 0 | $0 |